Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration: Twenty-Four–Week Results of an Uncontrolled Open-Label Clinical Study
| Autor: | Moshfeghi, Andrew A., Rosenfeld, Philip J., Puliafito, Carmen A., Michels, Stephan, Marcus, Erin N., Lenchus, Joshua D., Venkatraman, Anna S. |
|---|---|
| Zdroj: | In Ophthalmology 2006 113(11):2002-2011 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|